Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
Creator
Chiu-Yat Woo, Patrick
Li, Hongyan
Sun, Hongzhe
Ho, Pak-Leung
Gao, Peng
Lai, Tsz-Pui
Ma, Guixing
Wang, Runming
Zhang, Hongmin
Kao, Yi-Tsun
Kong, Hong
Zhang,
Gao, Hongmin
Kong,
Kong, Pok
Lai, Peng
Lam, Fu
Lam, Hong
Wang, Tsz-Pui
Source
PMC
abstract
Drug-resistant superbugs pose a huge threat to human health. Infections by Enterobacteriaceae producing metallo-β-lactamases (MBLs), e.g., New Delhi metallo-β-lactamase 1 (NDM-1) are very difficult to treat. Development of effective MBL inhibitors to revive the efficacy of existing antibiotics is highly desirable. However, such inhibitors are not clinically available till now. Here we show that an anti-Helicobacter pylori drug, colloidal bismuth subcitrate (CBS), and related Bi(III) compounds irreversibly inhibit different types of MBLs via the mechanism, with one Bi(III) displacing two Zn(II) ions as revealed by X-ray crystallography, leading to the release of Zn(II) cofactors. CBS restores meropenem (MER) efficacy against MBL-positive bacteria in vitro, and in mice infection model, importantly, also slows down the development of higher-level resistance in NDM-1-positive bacteria. This study demonstrates a high potential of Bi(III) compounds as the first broad-spectrum B1 MBL inhibitors to treat MBL-positive bacterial infection in conjunction with existing carbapenems.
has issue date
2018-01-30
(
xsd:dateTime
)
bibo:doi
10.1038/s41467-018-02828-6
bibo:pmid
29382822
has license
cc-by
sha1sum (hex)
49e1868b232e6ec98ae7cbc0745613925205e056
schema:url
https://doi.org/10.1038/s41467-018-02828-6
resource representing a document's title
Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
has PubMed Central identifier
PMC5789847
has PubMed identifier
29382822
schema:publication
Nat Commun
resource representing a document's body
covid:49e1868b232e6ec98ae7cbc0745613925205e056#body_text
is
schema:about
of
named entity 'irreversibly inhibit'
named entity 'mice'
named entity 'colloidal'
named entity 'study'
named entity 'ions'
named entity 'III'
named entity 'pose'
named entity 'inhibitors'
covid:arg/49e1868b232e6ec98ae7cbc0745613925205e056
named entity 'mechanism'
named entity 'MER'
named entity 'existing'
named entity 'Enterobacteriaceae'
named entity 'β-lactamase'
named entity 'bacteria'
named entity 'bacteria'
named entity 'ions'
named entity 'Drug-resistant'
named entity 'CBS'
named entity 'metallo'
named entity 'SDS-PAGE'
named entity 'bacteria'
named entity 'MBC'
named entity '300 nm'
named entity 'substrates'
named entity 'metallo'
named entity 'centrifugation'
named entity 'NDM-1'
named entity 'glycerol'
named entity 'broadspectrum'
named entity 'MDCK'
named entity 'mucin'
named entity 'cofactors'
named entity 'monotherapy'
named entity 'E. coli'
named entity 'B-factor'
named entity 'N-terminal'
named entity 'complexation'
named entity 'pH 4'
named entity 'MBC'
named entity 'NDM-1'
named entity 'supernatant'
named entity 'bicinchoninic acid assay'
named entity 'diffusion'
named entity 'antibiotic'
named entity 'plasmids'
named entity 'conformations'
named entity 'MIC'
named entity 'CBS'
named entity 'EDTA'
named entity 'rapid evolution'
named entity 'β-lactam antibiotic'
named entity 'quartz'
named entity 'SDS-PAGE'
named entity 'data set'
named entity 'bacteria'
named entity 'incubation'
named entity 'NDM-1'
named entity 'CBS'
named entity 'MIC'
named entity 'bismuth oxide'
named entity 'bacterial infection'
named entity 'bacteria'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 12
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software